Innovative Robotic Technology for Interventional Cardiology & Neurointervention
Robocath®, a wholly owned subsidiary of Stereotaxis, is a global leader in developing advanced robotic technology for endovascular interventions. We are pioneering a future where minimally-invasive treatment of stroke and cardiovascular diseases is enhanced by robotic precision and safety, automation and intelligence, and long-distance telesurgery.


